Free Trial
CNSX:VRT

Vertiv (VRT) Stock Price, News & Analysis

Vertiv logo

About Vertiv Stock (CNSX:VRT)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
2,475 shs
Average Volume
73,073 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Veritas Pharma Inc., through its subsidiary, Cannevert Therapeutics Ltd. operates as a pharmaceutical and IP development company. It develops proprietary cannabis strains for chronic and acute pains, nausea and vomiting, and post-traumatic stress disorders. The company was formerly known as Seashore Organic Medicine Inc. and changed its name to Veritas Pharma Inc. in December 2015. Veritas Pharma Inc. was incorporated in 2014 and is headquartered in Vancouver, Canada.

Receive VRT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vertiv and its competitors with MarketBeat's FREE daily newsletter.

VRT Stock News Headlines

Urgent: Make this trade before you hit your pillow tonight…
Most people waste 8 hours every night… And 227,916 hours in their lifetime… Dreaming about the life they wish they could live. But thanks to a little-known “loophole” in the markets after midnight...
See More Headlines

VRT Stock Analysis - Frequently Asked Questions

Shares of VRT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vertiv investors own include NVIDIA (NVDA), Arista Networks (ANET), ARM (ARM), PACCAR (PCAR), Meta Platforms (META), Micron Technology (MU) and Novo Nordisk A/S (NVO).

Industry, Sector and Symbol

Stock Exchange
CNSX
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Electronic Equipment
Current Symbol
CNSX:VRT
CIK
N/A
Fax
N/A
Employees
27,000
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (CNSX:VRT) was last updated on 6/1/2025 by MarketBeat.com Staff
From Our Partners